Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TTRAP-bleeding thromboelastography study of tranexamic acid in severe thrombocytopenia
2018-004756-38Phase 2Completed
- Sponsor
- Institut de Cancérologie Lucien Neuwirth
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of tranexamic acid in hematopoietic malignancies (3 arms), sponsored by Institut de Cancérologie Lucien Neuwirth. Primary endpoint: Evolution of maximum amplitude (EXTEM) on thromboelastogram. Started Dec 2018; status: completed.
02
Drugs
tranexamic acid
03
Conditions
hematopoietic malignancies
Beyond the preview
Go deeper on 2018-004756-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004756-38.